Constitutive versus activation-dependent cross-presentation of immune complexes by CD8+ and CD8- dendritic cells in vivo

被引:265
作者
den Haan, JMM [1 ]
Bevan, MJ [1 ]
机构
[1] Univ Washington, Dept Immunol, Howard Hughes Med Inst, Seattle, WA 98195 USA
关键词
antigen presentation; cytotoxic T lymphocyte; cross-priming; dendritic cell; Fc receptors;
D O I
10.1084/jem.20020295
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Murine splenic dendritic cells (DCs) can be divided into two subsets based on CD8alpha expression, but the specific role of each subset in stimulation of T cells is largely unknown. An important function of DCs is the ability to take up exogenous antigens and cross-present them in the context of major histocompatibility complex (MHC) class I molecules to CD8(+) T cells. We previously demonstrated that, when cell-associated ovalbumin (OVA) is injected into mice, only the CD8(+) DC subset cross-presents OVA in the context of MHC class I. In contrast to this selectivity with cell-associated antigen, we show here that both DC subsets isolated from mice injected with OVA/anti-OVA immune complexes (OVA-IC) cross-present OVA to CD8(+) T cells. The use of immunoglobulin G Fc receptor (FcgammaR) common gamma-chain-deficient mice revealed that the cross-presentation by CD8(+) DCs depended on the expression of gamma-chain-containing activating FcgammaRs, whereas cross-presentation by CD8+ DCs was not reduced in gamma-chain-deficient mice. These results suggest that although CD8(+) DCs constitutively cross-present exogenous antigens in the context of MFIC class I molecules, CD8(+) DCs only do so after activation, such as via ligation of FcRgammaRs. Cross-presentation of immune complexes may play an important role in autoimmune diseases and the therapeutic effect of antitumor antibodies.
引用
收藏
页码:817 / 827
页数:11
相关论文
共 64 条
[1]
In vivo CD4+ T cell tolerance induction versus priming is independent of the rate and number of cell divisions [J].
Adler, AJ ;
Huang, CT ;
Yochum, GS ;
Marsh, DW ;
Pardoll, DM .
JOURNAL OF IMMUNOLOGY, 2000, 164 (02) :649-655
[2]
Type II and III receptors for immunoglobulin G (IgG) control the presentation of different T cell epitopes from single IgG-complexed antigens [J].
Amigorena, S ;
Lankar, D ;
Briken, V ;
Gapin, L ;
Viguier, M ;
Bonnerot, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (04) :505-515
[3]
Definition of dendritic cell subpopulations present in the spleen, Peyer's patches, lymph nodes, and skin of the mouse [J].
Anjuère, F ;
Martín, P ;
Ferrero, I ;
Fraga, ML ;
del Hoyo, GM ;
Wright, N ;
Ardavin, C .
BLOOD, 1999, 93 (02) :590-598
[4]
Mouse type IIFN-producing cells are immature APCs with plasmacytoid morphology [J].
Asselin-Paturel, C ;
Boonstra, A ;
Dalod, M ;
Durand, I ;
Yessaad, N ;
Dezutter-Dambuyant, C ;
Vicari, A ;
O'Garra, A ;
Biron, C ;
Brière, F ;
Trinchieri, G .
NATURE IMMUNOLOGY, 2001, 2 (12) :1144-1150
[5]
Type 1 diabetes: new perspectives on disease pathogenesis and treatment [J].
Atkinson, MA ;
Eisenbarth, GS .
LANCET, 2001, 358 (9277) :221-229
[6]
Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements [J].
Barnden, MJ ;
Allison, J ;
Heath, WR ;
Carbone, FR .
IMMUNOLOGY AND CELL BIOLOGY, 1998, 76 (01) :34-40
[7]
Help for cytotoxic-T-cell responses is mediated by CD40 signalling [J].
Bennett, SRM ;
Carbone, FR ;
Karamalis, F ;
Flavell, RA ;
Miller, JFAP ;
Heath, WR .
NATURE, 1998, 393 (6684) :478-480
[8]
BEVAN MJ, 1976, J IMMUNOL, V117, P2233
[10]
Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice [J].
Björck, P .
BLOOD, 2001, 98 (13) :3520-3526